The Billionaire Behind the NHS Data Deal That MPs Want Dead
Imagine handing the keys to your most private medical records — your diagnosis, your DNA, your children’s vaccination history — to a company that also builds surveillance software for militaries. That’s exactly what the UK’s National Health Service did when it signed a £330 million contract with Palantir, the data analytics firm co-founded by Peter Thiel. But now, a rebellion is brewing.
Two parliamentary committees have urged the next Labour government to tear up the deal. MPs on the health and social care select committee cite “serious mistrust” among patients and doctors. They point to contested evidence of benefits and the existence of cheaper, homegrown alternatives. Last month, the science and technology committee recommended triggering a break clause in February 2027 and building an in-house replacement. This isn’t just a political spat — it’s a battle over the soul of public healthcare.
Peter Thiel is no stranger to controversy. The libertarian billionaire, a vocal Donald Trump supporter, made his fortune co-founding PayPal and Palantir. He has donated millions to right-wing causes, from climate-change denial groups to the campaign of Senator Josh Hawley. But his company’s work with the NHS represents a different kind of giving: the sale of a “federated data platform” (FDP) designed to unify and analyse vast amounts of sensitive health information. The promise? Better predictions, faster diagnoses, more efficient care. The reality, according to critics, is a mediocre system that erodes the trust on which the NHS depends.
The mechanics of the deal are dizzying. Palantir’s software ingests data from GP surgeries, hospitals, and ambulance trusts, then uses algorithms to spot patterns. But 117 NHS data and technology workers — including senior data professionals — broke ranks in a letter to Health Secretary James Murray. They warned that patient privacy protections are inadequate, that data completeness will be compromised by eroded trust, and that “data structures are at risk of misuse.” One anonymous signatory, a senior data professional, said bluntly: “The FDP has not shown me any significant technological benefits whatsoever. A frankly mediocre software is being forced on NHS data systems at the expense of patient trust, professional integrity and the fundamental values of the NHS.”
The broader impact stretches far beyond one contract. If the deal collapses, it will signal that the NHS — a beloved public institution — cannot be treated as a testing ground for Silicon Valley’s most controversial tools. It will vindicate the growing movement for “digital sovereignty” in healthcare, where data stays in public hands. And it will force a reckoning for Thiel, whose philanthropy has long been intertwined with his business interests. His charitable giving, through the Thiel Foundation, has funded everything from seasteading to anti-aging research. But this NHS episode reveals a darker pattern: using the language of innovation to sell surveillance-adjacent technology to cash-strapped public services.
For the culture of giving, this story is a cautionary tale. True philanthropy isn’t just about writing cheques — it’s about respecting the values of the communities you claim to serve. The NHS staff who spoke out are everyday heroes: data professionals, nurses, and doctors who refused to let a billionaire’s software compromise their patients’ trust. They remind us that the most powerful gift isn’t a platform — it’s the courage to say no.
